Exagen sees Q3 revenue $10M-$10.5M, consensus $11.76M

The company said, “Cash and cash equivalents were $31.5 million as of June 30, 2023, which reflects the $10 million principal prepayment we made when refinancing our debt on April 28 of this year and an increase in accounts receivable to $16.2 million.”